Skip to main content
Skip to header right navigation
Skip to site footer

Endogenex

Bringing New Energy to the Treatment of Type 2 Diabetes

ReCET
Patients
Clinical Providers
About Us
- News
- Contact
Clinical Studies

Jennifer Strumbel

Endogenex

Endogenex™ Appoints Medical Device Executive, Stacey Pugh, Chief Executive Officer

* Caution: Exclusively a clinical investigational device. Limited by federal (or United States or similar) law to investigational use. Not for sale in any geography.

Endogenex, Inc.
151 Cheshire Ln N #400
Plymouth, MN 55441
+1 763-251-6820
info@endogenex.com

Facebook
Twitter
LinkedIn
Vimeo

Join our mailing list

First name

Last name

Email Address

Δ

Endogenex^TM and ReCET^TM are registered trademarks of Endogenex, Inc. in the United States and other countries.

Copyright © 2023 Endogenex, Inc. All rights reserved.